CD 19+ acute leukemia

Clinical trials for CD 19+ acute leukemia explained in plain language.

Never miss a new study

Get alerted when new CD 19+ acute leukemia trials appear

Sign up with your email to follow new studies for CD 19+ acute leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New infusion strategy aims to keep CAR t cells fighting leukemia longer

Disease control Ongoing

This pilot study tests whether giving special immune cells called T-APCs after CAR T cell therapy can help the CAR T cells persist longer in the body and prevent leukemia from returning. It involves 30 children and young adults with relapsed or refractory CD19+ leukemia who have …

Matched conditions: CD 19+ ACUTE LEUKEMIA

Phase 1 • Sponsor: Seattle Children's Hospital • Aim: Disease control

Last updated Jun 27, 2026 13:02 UTC

CD 19+ acute leukemia

Get alerted when new CD 19+ acute leukemia trials appear

New infusion strategy aims to keep CAR t cells fighting leukemia longer